10-122461596-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002775.5(HTRA1):c.-57C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0164 in 1,134,978 control chromosomes in the GnomAD database, including 206 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 20 hom., cov: 32)
Exomes 𝑓: 0.017 ( 186 hom. )
Consequence
HTRA1
NM_002775.5 5_prime_UTR
NM_002775.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.03
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 10-122461596-C-A is Benign according to our data. Variant chr10-122461596-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 299042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0138 (2041/148090) while in subpopulation NFE AF= 0.0169 (1123/66366). AF 95% confidence interval is 0.0161. There are 20 homozygotes in gnomad4. There are 951 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTRA1 | NM_002775.5 | c.-57C>A | 5_prime_UTR_variant | 1/9 | ENST00000368984.8 | NP_002766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTRA1 | ENST00000368984 | c.-57C>A | 5_prime_UTR_variant | 1/9 | 1 | NM_002775.5 | ENSP00000357980.3 | |||
HTRA1 | ENST00000648167.1 | c.154+2887C>A | intron_variant | ENSP00000498033.1 |
Frequencies
GnomAD3 genomes AF: 0.0138 AC: 2041AN: 147978Hom.: 20 Cov.: 32
GnomAD3 genomes
AF:
AC:
2041
AN:
147978
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0145 AC: 998AN: 68984Hom.: 12 AF XY: 0.0149 AC XY: 596AN XY: 40040
GnomAD3 exomes
AF:
AC:
998
AN:
68984
Hom.:
AF XY:
AC XY:
596
AN XY:
40040
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0168 AC: 16540AN: 986888Hom.: 186 Cov.: 13 AF XY: 0.0168 AC XY: 8294AN XY: 493270
GnomAD4 exome
AF:
AC:
16540
AN:
986888
Hom.:
Cov.:
13
AF XY:
AC XY:
8294
AN XY:
493270
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0138 AC: 2041AN: 148090Hom.: 20 Cov.: 32 AF XY: 0.0132 AC XY: 951AN XY: 72120
GnomAD4 genome
AF:
AC:
2041
AN:
148090
Hom.:
Cov.:
32
AF XY:
AC XY:
951
AN XY:
72120
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Macular degeneration Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at